Virtual reality (VR) headsets could restore visual function in patients with moderate to severe visual impairment caused by conditions such as age-related macular degeneration and glaucoma. So claims a feature in the New York Times, describing a remotely controlled, wearable device called IrisVision, which enhances the image generated by patients’ remaining visual areas to enable clearer vision (Morrissey, 2020).
Sign in to continue
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Glaucoma is the second leading cause of irreversible sight loss in the UK and affects over one million people, which is predicted to rise by 100,000 cases to 1.145 million people by 2030*.
The College of Optometrists has published its first issue of Ophthalmic and Physiological Optics (OPO), its flagship international and interdisciplinary research journal for contemporary vision science and optometry, with its new publishing partner Springer Nature this month.